Last edition
News about "Chhatrapati Sambhajinagar (Aurangabad)"
Glenmark's Aurangabad Facility Clears US FDA Inspection With Zero Observations
Glenmark Pharmaceuticals announced that the US Food and Drug Administration (US FDA) has successfully completed a pre-approval inspection of its formulations manufacturing facility in Chhatrapati Sambhajinagar (Aurangabad).
Chhatrapati Sambhajinagar (Aurangabad) | 01/12/2025 | By Dineshwori | 467
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members